uniquemedicallabs.com

TIRZEPATIDE

Price range: $190.00 through $575.00

Facebook
Email
WhatsApp

Tirzepatide is a 39-amino acid linear synthetic peptide and dual agonist of the GIP and GLP-1 receptors developed to stimulate glucose-dependent insulin secretion and suppress glucagon through potent activation of the GLP-1R and GIPR signaling pathways. It is utilized in metabolic research examining glucose-lowering mechanisms, gastric emptying kinetics, food intake regulation, and the pharmacokinetic effects of C20 fatty diacid conjugation on albumin-bound peptide half-life.

For research use only. Not for human consumption.

Additional information

Select

10MG, 20MG, 30MG, 60MG

Research Applications:

The study of Tirzepatide as a dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors is primarily relevant to research questions where synergistic metabolic modulation and glucose-dependent glycemic control are the central objectives. Example research contexts include:

  • Glycemic Homeostasis Models: Investigation of glucose-stimulated insulin secretion (GSIS) and the coordinated suppression of glucagon for the treatment of type 2 diabetes (T2D).

  • Body Composition and Obesity Studies: Research into reduced food intake and weight loss mediated by the central and peripheral activation of satiety pathways.

  • Gastric Emptying Kinetics: Models focused on the delay of gastrointestinal transit and its impact on lowering postprandial glucose concentrations.

  • Long-Acting Peptide Pharmacokinetics: Research regarding fatty acid conjugation (C20 diacid moiety) and its albumin binding properties to prolong plasma half-life.

Because the concept of “dual agonism” proposes efficacy superior to monotherapy, this approach frames metabolic synergy as a hypothesis: if Tirzepatide simultaneously activates the GIPR and GLP-1R, it may overcome the therapeutic bottlenecks of selective agonists (such as insulin resistance or gastrointestinal tolerability). In preclinical designs, this combined administration within a single molecule may produce additive or multiplicative improvements in beta-cell function, insulin sensitivity, and adipose tissue organization—depending on the model choice and specific endpoints.

⚠️ Important Warnings and Disclaimers

Product Guidelines

  • Product intended for experimental and research purposes only.

  • Do not use without proper technical knowledge.

  • Keep refrigerated as per storage guidelines.

  • Results may vary based on genetics, diet, and lifestyle.

  • Keep out of reach of children.

  • Store according to technical instructions.

  • Do not reuse vials or materials.

  • Do not purchase if you have any doubts regarding its use.

Limitation of Liability The company is not responsible for:

  • Misuse or incorrect administration.

  • Adverse reactions or interactions with other medications.

  • Consequences resulting from self-medication.

  • The buyer assumes full responsibility for all risks associated with handling and utilization.

📌 Legal Compliance This product is marketed as a research chemical, in compliance with international laboratory supply practices. The sale of this product does not constitute an offer for medical treatment.